ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
ABVC BioPharma, Inc. (ABVC) had Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net of $43.65 million as of 2019-02-08, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet · last filed 2022-11-14
- 2019-02-08: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $43.65M.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net $43.53M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |
|---|---|
| 2019-02-08 | $43.65M 10-Q · filed 2022-11-14 |
| 2018-12-31 | $43.53M 10-K · filed 2019-04-15 |